$2.5T
Total marketcap
$65.61B
Total volume
BTC 50.04%     ETH 16.21%
Dominance

Mesa Laboratories, Inc. MLI.F Stock

96.5 EUR {{ price }} 1.047121% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
528.07M EUR
LOW - HIGH [24H]
96.5 - 96.5 EUR
VOLUME [24H]
6 EUR
{{ volume }}
P/E Ratio
643.33
Earnings per share
0.15 EUR

Mesa Laboratories, Inc. Price Chart

Mesa Laboratories, Inc. MLI.F Financial and Trading Overview

Mesa Laboratories, Inc. stock price 96.5 EUR
Previous Close 124 EUR
Open 121 EUR
Bid 121 EUR x N/A
Ask 124 EUR x N/A
Day's Range 121 - 121 EUR
52 Week Range 118 - 208 EUR
Volume 30 EUR
Avg. Volume 0 EUR
Market Cap 649.77M EUR
Beta (5Y Monthly) 0.736971
PE Ratio (TTM) 711.7647
EPS (TTM) 0.15 EUR
Forward Dividend & Yield 0.6 (0.47%)
Ex-Dividend Date May 30, 2023
1y Target Est 315 EUR

MLI.F Valuation Measures

Enterprise Value 840.97M EUR
Trailing P/E 711.7647
Forward P/E 55.25114
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 2.9658809
Price/Book (mrq) 1.6511784
Enterprise Value/Revenue 3.839
Enterprise Value/EBITDA 22.641

Trading Information

Mesa Laboratories, Inc. Stock Price History

Beta (5Y Monthly) 0.736971
52-Week Change -26.16%
S&P500 52-Week Change 20.43%
52 Week High 208 EUR
52 Week Low 118 EUR
50-Day Moving Average 144.68 EUR
200-Day Moving Average 154.75 EUR

MLI.F Share Statistics

Avg. Volume (3 month) 0 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 5.37M
Float 5.14M
Short Ratio N/A
% Held by Insiders 5.72%
% Held by Institutions 97.01%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.64
Trailing Annual Dividend Yield 0.51%
5 Year Average Dividend Yield N/A
Payout Ratio 3.7647
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2023
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End March 31, 2024

Profitability

Profit Margin 0.42%
Operating Margin (ttm) 1.51%
Gross Margin 61.02%
EBITDA Margin 16.95%

Management Effectiveness

Return on Assets (ttm) 0.30%
Return on Equity (ttm) 0.23%

Income Statement

Revenue (ttm) 219.08M EUR
Revenue Per Share (ttm) 41.17 EUR
Quarterly Revenue Growth (yoy) -5.60%
Gross Profit (ttm) N/A
EBITDA 37.14M EUR
Net Income Avi to Common (ttm) 930K EUR
Diluted EPS (ttm) 0.17
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 32.91M EUR
Total Cash Per Share (mrq) 6.13 EUR
Total Debt (mrq) 191.89M EUR
Total Debt/Equity (mrq) 48.77 EUR
Current Ratio (mrq) 2.744
Book Value Per Share (mrq) 73.281

Cash Flow Statement

Operating Cash Flow (ttm) 27.98M EUR
Levered Free Cash Flow (ttm) 25.02M EUR

Profile of Mesa Laboratories, Inc.

Country Germany
State CO
City Lakewood
Address 12100 West Sixth Avenue
ZIP 80228
Phone 303 987 8000
Website https://www.mesalabs.com
Industry Scientific & Technical Instruments
Sector(s) Technology
Full Time Employees 698

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Q&A For Mesa Laboratories, Inc. Stock

What is a current MLI.F stock price?

Mesa Laboratories, Inc. MLI.F stock price today per share is 96.5 EUR.

How to purchase Mesa Laboratories, Inc. stock?

You can buy MLI.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Mesa Laboratories, Inc.?

The stock symbol or ticker of Mesa Laboratories, Inc. is MLI.F.

Which industry does the Mesa Laboratories, Inc. company belong to?

The Mesa Laboratories, Inc. industry is Scientific & Technical Instruments.

How many shares does Mesa Laboratories, Inc. have in circulation?

The max supply of Mesa Laboratories, Inc. shares is 5.47M.

What is Mesa Laboratories, Inc. Price to Earnings Ratio (PE Ratio)?

Mesa Laboratories, Inc. PE Ratio is 643.33330000 now.

What was Mesa Laboratories, Inc. earnings per share over the trailing 12 months (TTM)?

Mesa Laboratories, Inc. EPS is 0.15 EUR over the trailing 12 months.

Which sector does the Mesa Laboratories, Inc. company belong to?

The Mesa Laboratories, Inc. sector is Technology.